43 results on '"Mendes FSNS"'
Search Results
2. Physical activity levels during COVID-19 pandemic and its associated factors in patients with Chagas disease.
- Author
-
Xavier IGG, Andrade PM, Vitor RL, Barros TC, Portela LF, de Holanda MT, Sangenis LHC, Sperandio da Silva GM, Mazzoli-Rocha F, Mendes FSNS, da Costa AR, Quintana MSB, Hasslocher-Moreno AM, Araujo IL, Junqueira ACV, Pinheiro RO, Georg I, Paravidino VB, Gonçalves TR, Saraiva RM, and Mediano MFF
- Abstract
Background: A better understanding of the consequences of the Coronavirus Disease 2019 (COVID-19) pandemic on lifestyle of patients with Chagas disease (ChD) is of paramount importance to facilitate the implementation of intervention strategies tailored to this specific population., Objective: The present study aimed to evaluate the level of physical activity (PA) in Chagas disease (ChD) patients during the Coronavirus Disease 2019 (COVID-19) pandemic and its main associated factors., Methods: This is a cross-sectional study with 187 patients of both sexes, aged ≥18 years, followed in a national infectious disease center (Rio de Janeiro, Brazil). The level of PA was determined by the International Physical Activity Questionnaire short version and expressed in terms of total volume of physical activity (PA) (MET-minutes per week). Individuals were classified as physically active following the 2020 World Health Organization PA guideline. The exposure variables were age, sex, race, marital status, schooling, income per capita , number of rooms per domicile, number of residents per domicile, body mass index, clinical form of ChD, COVID-19 antibodies, comorbidities, self-reported anxiety, self-reported depression, self-reported fear, and self-reported sadness. The association between the exposure variables with total PA (as a continuous variable) was determined using univariate and multivariate linear regression models., Results: Mean age was 61.1 ± 11.6 years. Most (62%) were women and self-declared their race as mixed (50.8%). The percentage of physically active individuals according to was 52%. The variables independently associated with total PA levels were non-white race (Exp β = 1.39; 95% CI 1.02 to 1.90), dyslipidemia (Exp β = 0.73; 95% CI 0.56 to 0.95) and self-reported depression during quarantine (Exp β = 0.71; 95% CI 0.52 to 0.96)., Conclusion: Non-white race was positively associated with total levels of PA, while dyslipidemia, and self-reported depression during quarantine were negatively associated with total levels of PA. The identification of associated factors can facilitate the development of tailored strategies to increase PA levels ChD patients., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Xavier, Andrade, Vitor, Barros, Portela, de Holanda, Sangenis, Sperandio da Silva, Mazzoli-Rocha, Mendes, da Costa, Quintana, Hasslocher-Moreno, Araujo, Junqueira, Pinheiro, Georg, Paravidino, Gonçalves, Saraiva and Mediano.)
- Published
- 2024
- Full Text
- View/download PDF
3. Inspiratory muscle endurance is similarly reduced in the early and late stages of chronic Chagas heart disease.
- Author
-
Pinto Diniz C, Felix Mediano MF, Rodrigues Junior LF, Mendes FSNS, Magalhães Saraiva R, Horta Veloso H, Rodrigues da Costa A, Hasslocher-Moreno AM, Borghi-Silva A, Silvestre de Sousa A, and Mazzoli-Rocha F
- Subjects
- Humans, Cross-Sectional Studies, Male, Female, Middle Aged, Adult, Chronic Disease, Heart Failure physiopathology, Muscle Strength physiology, Inhalation physiology, Muscle Weakness physiopathology, Physical Endurance, Aged, Respiratory Muscles physiopathology, Chagas Cardiomyopathy physiopathology
- Abstract
Objective: Inspiratory muscle strength (IMS) appears to be reduced in subjects with chronic Chagas heart disease (CHD), especially in the presence of heart failure (HF). However, only one study about IMS and inspiratory muscle endurance (IME) in those with CHD without heart failure is available. This study aimed to compare IMS and IME in subjects with CHD in the presence and absence of HF., Methods: This is a cross-sectional study in which 30 CHD adult patients were divided into CHD-CC group (initial phase of CHD, without HF; n = 15) and CHD-HF group (advanced phase of CHD, with HF; n = 15). We assessed IMS by maximum inspiratory pressure (MIP) and IME by incremental (Pthmax) and constant load (TLim) tests. Reduced IMS and IME were considered by predicted MIP values <70% and Pthmax/MIP <75%, respectively., Results: Inspiratory muscle weakness (IMW) was more frequent in CHD-HF than in CHD-CC (46.7% vs. 13.3%; p = 0.05), and both groups had high frequencies of reduced IME (93.3% CHD-CC vs. 100.0% CHD-HF; p = 0.95). Age-adjusted logistic regression analysis using HF as a dependent variable showed that HF was associated with an increased chance of IMW compared with the CHD-CC group (OR = 7.47; p = 0.03; 95% CI 1.20-46.19)., Conclusion: This study suggests that, in patients with CHD, HF is associated with IMW, and that reduction of IME is already present in the initial phase, similar to the advanced phase with HF., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
4. Chagas heart disease is associated with decreased physical activity levels: A cross-sectional analysis.
- Author
-
Ribeiro LG, Gonçalves TR, Paravidino VB, Costa HS, Rodrigues Junior LF, Mazzoli-Rocha F, Sperandio da Silva GM, Mendes FSNS, Saraiva RM, Hasslocher-Moreno AM, and Mediano MFF
- Abstract
Background: Studies evaluating physical activity (PA) levels in individuals with Chagas disease (CD) are still scarce. The present study aimed to evaluate PA levels in CD individuals and examine their association with Chagas heart disease (ChHD)., Methods: We included patients with CD regularly followed in a reference center for treatment of infectious diseases. PA levels were assessed using the short version of the International Physical Activity Questionnaire (IPAQ). ChHD was determined following the Brazilian Consensus on Chagas Disease. The association between ChHD and levels of PA (total, walking, moderate, and vigorous) as a continuous variable was fitted using generalized linear models. Logistic regression models were fitted to evaluate the association between ChHD and meeting WHO's PA recommendations., Results: Among the 361 participants included in the analysis (60.7 ± 10.7 years; 56.2 % women), 58.1 % (n = 210) complied with the WHO's PA recommendations. After adjustments for potential confounders, regression analyses revealed that ChHD without heart failure was significantly associated with reduced vigorous PA (Exp β 0.32 95 % CI 0.10 to 0.98). ChHD with heart failure had significantly lower levels of total (Exp β 0.61 95 % CI 0.44 to 0.84) and moderate (Exp β 0.59 95 % CI 0.39 to 0.89) PA. ChHD with heart failure had a lower odd of meeting the PA recommendation in comparison to those with no cardiac involvement (OR 0.48 95 % CI 0.24 to 0.97)., Conclusions: We found low levels of PA among individuals with CD. Presence of ChHD (mainly with HF) was associated with decreased levels of PA., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
5. Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial.
- Author
-
Vieira MC, Mendes FSNS, da Silva PS, da Silva GMS, Mazzoli-Rocha F, de Sousa AS, Saraiva RM, de Holanda MT, Kasal DAB, Costa HS, Borges JP, Reis MS, Rodrigues Junior LF, Hasslocher-Moreno AM, do Brasil PEAA, and Mediano MFF
- Subjects
- Humans, Quality of Life, Stroke Volume, Ventricular Function, Left, Exercise Therapy methods, Exercise, Persistent Infection, Cardiac Rehabilitation methods, Chagas Cardiomyopathy therapy, Heart Failure
- Abstract
To investigate the effect of an exercise-based cardiac rehabilitation program on the quality of life (QoL) of patients with chronic Chagas cardiomyopathy (CCC). PEACH study was a single-center, superiority randomized clinical trial of exercise training versus no exercise (control). The sample comprised Chagas disease patients with CCC, left ventricular ejection fraction < 45%, without or with HF symptoms (CCC stages B2 or C, respectively). QoL was assessed at baseline, after three months, and at the end of six months of follow-up using the SF-36 questionnaire. Patients randomized for the exercise group (n = 15) performed exercise training (aerobic, strength and stretching exercises) for 60 min, three times a week, during six months. Patients in the control group (n = 15) were not provided with a formal exercise prescription. Both groups received identical nutritional and pharmaceutical counseling during the study. Longitudinal analysis of the effects of exercise training on QoL, considering the interaction term (group × time) to estimate the rate of changes between groups in the outcomes (represented as beta coefficient), was performed using linear mixed models. Models were fitted adjusting for each respective baseline QoL value. There were significant improvements in physical functioning (β = + 10.7; p = 0.02), role limitations due to physical problems (β = + 25.0; p = 0.01), and social functioning (β = + 19.2; p < 0.01) scales during the first three months in the exercise compared to the control group. No significant differences were observed between groups after six months. Exercise-based cardiac rehabilitation provided short-term improvements in the physical and mental aspects of QoL of patients with CCC.Trial registration: ClinicalTrials.gov Identifier: NCT02517632; August 7, 2015., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
6. Inspiratory Muscle Strength in Chagas Cardiomyopathy: A Systematic Scoping Review.
- Author
-
Mazzoli-Rocha F, Diniz CP, Rezende DPR, Mendes FSNS, Hasslocher-Moreno AM, Sousa AS, Saraiva RM, Borghi-Silva A, Mediano MFF, and Alexandre DJA
- Subjects
- Adult, Humans, Cross-Sectional Studies, Muscle Strength physiology, Chronic Disease, Brazil, Respiratory Muscles, Chagas Cardiomyopathy
- Abstract
The increase in inflammatory markers associated with persistent chronic fibrosing myocarditis, a characteristic of chronic Chagas disease, can result in a reduction in inspiratory muscle strength (IMS) in Chagas cardiomyopathy (CC). However, literature in this field is still scarce. This review aimed to map and summarize the evidence regarding IMS in patients with CC. The inclusion criteria included reports with adult participants with a CC diagnosis, with or without heart failure (HF). The core concept examined was the maximum inspiratory pressure evaluated in the untrained and trained groups in the pre-training period. The context was open, including but not limited to hospitals and health centers. Two authors independently identified eligible studies and extracted the data. Descriptive synthesis was used as the primary strategy for analyzing the results. Nine studies (five clinical trials, three cross-sectional, and one cohort) were included. The CC classification differed among the studies, with no mention of HF in five and no CC staging specification in six. IMS was assessed using a manovacuometer, and only six studies analyzed and interpreted the data concerning the predicted values. The CC population with HF appeared to have impaired IMS. All studies involved only Brazilian volunteers. In conclusion, randomized clinical trials evaluating IMS and the effects of inspiratory muscle training need to be conducted to better understand the prevalence and risk of inspiratory muscle weakness in the CC population, as well as the effects of training. Such studies should be conducted at different stages of CC in different populations and countries.
- Published
- 2023
- Full Text
- View/download PDF
7. Guidelines for Trypanosoma cruzi-HIV Co-infection and other Immunosuppressive Conditions: Diagnosis, Treatment, Monitoring, and Implementation from the International Network of Care and Studies - 2023.
- Author
-
Almeida EA, Mendes FSNS, Ramos Júnior AN, Sousa AS, Pavan TBS, Mediano MFF, Ostermayer AL, Hasslocher-Moreno AM, Britto CFPC, Novaes CG, Correia D, Santos FLN, Silva GMSD, Fernandez ML, Lima MM, Carvalho NB, Moreira ODC, Albajar-Viñas P, Leite RM, Palmeira SL, Costa VMD, and Yasuda MAS
- Subjects
- Humans, Trypanosoma cruzi, Coinfection, HIV Infections
- Published
- 2023
- Full Text
- View/download PDF
8. Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.
- Author
-
de Brito ASX, Moll-Bernardes RJ, Pinheiro MVT, Camargo GC, Siqueira FPR, Oliveira RS, Glavam AP, de Almeida SA, de Holanda MT, Sangenis LHC, Mendes FSNS, Rosado-de-Castro PH, and de Sousa AS
- Subjects
- Humans, 3-Iodobenzylguanidine, Contrast Media, Gadolinium, Death, Sudden, Cardiac prevention & control, Fibrosis, Autonomic Denervation, Chagas Cardiomyopathy complications, Chagas Cardiomyopathy diagnostic imaging, Ventricular Premature Complexes, Myocardial Ischemia, Coronary Artery Disease, Chagas Disease complications, Chagas Disease diagnostic imaging
- Abstract
Background: Sudden cardiac death (SCD) can be the first clinical event of Chagas heart disease (CHD). However, current guidelines contain no clear recommendation for early cardioverter-defibrillator implantation. Using imaging modalities, we evaluated associations among autonomic denervation, myocardial hypoperfusion, fibrosis and ventricular arrhythmia in CHD., Methods and Results: Twenty-nine patients with CHD and preserved left ventricular function underwent 123I-metaiodobenzylguanidine (MIBG) scintigraphy, 99mTc-methoxyisobutylisonitrile (MIBI) myocardial perfusion and cardiac magnetic resonance imaging (MRI). They were divided into arrhythmic (≥ 6 ventricular premature complexes/h and/or non-sustained ventricular tachycardia on 24-hour Holter, n = 15) and non-arrhythmic (< 6 ventricular premature complexes/h and no ventricular tachycardia; n = 14) groups. The arrhythmic group had higher denervation scores from MIBG imaging (23.2 ± 18.7 vs 5.6 ± 4.9; P < .01), hypoperfusion scores from MIBI SPECT (4.7 ± 6.8 vs 0.29 ± 0.6: P = .02), innervation/perfusion mismatch scores (18.5 ± 17.5 vs 5.4 ± 4.8; P = .01) and fibrosis by late gadolinium enhancement on MRI (14.3% ± 13.5% vs 4.0% ± 2.9%; P = .04) than the non-arrhythmic group., Conclusion: These imaging parameters were associated with ventricular arrhythmia in early CHD and may enable risk stratification and the implementation of primary preventive strategies for SCD., (© 2023. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.)
- Published
- 2023
- Full Text
- View/download PDF
9. Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trial.
- Author
-
Mediano MFF, Ribeiro LG, Silva RS, Xavier IGG, Vieira MC, Gonçalves TR, Paravidino VB, Borges JP, Rodrigues Junior LF, Costa HS, Reis MS, Liporagi-Lopes LC, Martinez-Amezcua P, Silva PS, Sperandio Da Silva GM, Sousa AS, Holanda MT, Veloso HH, Carneiro FM, Mazzoli-Rocha F, Costa AR, Saraiva RM, Mendes FSNS, Sangenis LHC, and Hasslocher-Moreno AM
- Abstract
[This corrects the article DOI: 10.3389/fmed.2022.1087188.]., (Copyright © 2023 Mediano, Ribeiro, Silva, Xavier, Vieira, Gonçalves, Paravidino, Borges, Rodrigues Junior, Costa, Reis, Liporagi-Lopes, Martinez-Amezcua, Silva, Sperandio Da Silva, Sousa, Holanda, Veloso, Carneiro, Mazzoli-Rocha, Costa, Saraiva, Mendes, Sangenis and Hasslocher-Moreno.)
- Published
- 2023
- Full Text
- View/download PDF
10. SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023.
- Author
-
Marin-Neto JA, Rassi A Jr, Oliveira GMM, Correia LCL, Ramos Júnior AN, Luquetti AO, Hasslocher-Moreno AM, Sousa AS, Paola AAV, Sousa ACS, Ribeiro ALP, Correia Filho D, Souza DDSM, Cunha-Neto E, Ramires FJA, Bacal F, Nunes MDCP, Martinelli Filho M, Scanavacca MI, Saraiva RM, Oliveira Júnior WA, Lorga-Filho AM, Guimarães AJBA, Braga ALL, Oliveira AS, Sarabanda AVL, Pinto AYDN, Carmo AALD, Schmidt A, Costa ARD, Ianni BM, Markman Filho B, Rochitte CE, Macêdo CT, Mady C, Chevillard C, Virgens CMBD, Castro CN, Britto CFPC, Pisani C, Rassi DDC, Sobral Filho DC, Almeida DR, Bocchi EA, Mesquita ET, Mendes FSNS, Gondim FTP, Silva GMSD, Peixoto GL, Lima GG, Veloso HH, Moreira HT, Lopes HB, Pinto IMF, Ferreira JMBB, Nunes JPS, Barreto-Filho JAS, Saraiva JFK, Lannes-Vieira J, Oliveira JLM, Armaganijan LV, Martins LC, Sangenis LHC, Barbosa MPT, Almeida-Santos MA, Simões MV, Yasuda MAS, Moreira MDCV, Higuchi ML, Monteiro MRCC, Mediano MFF, Lima MM, Oliveira MT, Romano MMD, Araujo NNSL, Medeiros PTJ, Alves RV, Teixeira RA, Pedrosa RC, Aras Junior R, Torres RM, Povoa RMDS, Rassi SG, Alves SMM, Tavares SBDN, Palmeira SL, Silva Júnior TLD, Rodrigues TDR, Madrini Junior V, Brant VMDC, Dutra WO, and Dias JCP
- Subjects
- Humans, Chagas Disease complications, Chagas Disease diagnosis, Chagas Disease therapy, Cardiomyopathies diagnosis, Cardiomyopathies therapy, Chagas Cardiomyopathy diagnosis, Chagas Cardiomyopathy therapy
- Published
- 2023
- Full Text
- View/download PDF
11. Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease.
- Author
-
Mendes VG, Rimolo L, de Lima ACB, Ferreira RR, Oliveira LS, Nisimura LM, Horita SIM, Costa AR, da Silva GMS, Sangenis LHC, Mendes FSNS, Sousa AS, Veloso HH, Holanda MT, Mediano MFF, Waghabi MC, Garzoni LR, Moreira OC, Britto C, Cunha AB, Hasslocher-Moreno AM, and Saraiva RM
- Subjects
- Male, Humans, Female, Longitudinal Studies, Prospective Studies, Natriuretic Peptide, Brain, Echocardiography methods, Biomarkers, Prognosis, Ventricular Function, Left, Stroke Volume, Atrial Fibrillation, Chagas Disease complications
- Abstract
Background Chagas disease (CD) presents an ominous prognosis. The predictive value of biomarkers and new echocardiogram parameters in adjusted models have not been well studied. Methods and Results There were 361 patients with chronic CD (57.6% men, 61±11 years of age, clinical forms: indeterminate 27.1%, cardiac 56.6%, digestive 3.6%, cardiodigestive 12.7%) included in this single-center, observational, prospective longitudinal study. Echocardiographic evaluation included strain analyses of left atrial, left ventricular (LV), and right ventricular and 3-dimensional analyses of left atrial and LV volumes. Biomarkers included cardiac troponin I, brain natriuretic peptide, transforming growth factor β1, tumor necrosis factor, matrix metalloproteinases, and Trypanosoma cruzi polymerase chain reaction. The studied end point was a composite of CD-related mortality, heart transplant, hospital admission due to worsening heart failure, or new cardiac device insertion. Event-free survival was analyzed by multivariable regression analyses adjusted for competing risks. P values <0.05 were considered significant. The composite event occurred in 79 patients after 4.9±2.0 years follow-up. LV end-diastolic volume (hazard ratio [HR], 1.01 [95% CI, 1.00-1.02]; P =0.02), peak negative global atrial strain (HR, 1.08 [95% CI, 1.00-1.17]; P =0.04), LV global circumferential strain (HR, 1.12 [95% CI, 1.04-1.21]; P =0.003), LV torsion (HR, 0.55 [95% CI, 0.35-0.81]; P =0.003), brain natriuretic peptide (HR, 2.03 [95% CI, 1.23-3.34]; P =0.005), and positive T cruzi polymerase chain reaction (HR, 1.80 [95% CI, 1.12-2.91]; P =0.01) were end point predictors independent from age, sex, 2-dimensional echocardiographic indexes, hypertension, previous cardiac device, and CD cardiac form. Conclusions Two-dimensional strain- and 3-dimensional-derived parameters, brain natriuretic peptide, and positive T cruzi polymerase chain reaction can be useful for prediction of CD cardiovascular events.
- Published
- 2023
- Full Text
- View/download PDF
12. Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trial.
- Author
-
Mediano MFF, Ribeiro LG, Silva RS, Xavier IGG, Vieira MC, Gonçalves TR, Paravidino VB, Borges JP, Rodrigues Junior LF, Costa HS, Reis MS, Liporagi-Lopes LC, Martinez-Amezcua P, Silva PS, Sperandio Da Silva GM, Sousa AS, Holanda MT, Veloso HH, Carneiro FM, Mazzoli-Rocha F, Costa AR, Saraiva RM, Mendes FSNS, Sangenis LHC, and Hasslocher-Moreno AM
- Abstract
Background: Chagas disease (CD) is a neglected endemic disease with worldwide impact due to migration. Approximately 50-70% of individuals in the chronic phase of CD present the indeterminate form, characterized by parasitological and/or serological evidence of Trypanosoma cruzi infection, but without clinical signs and symptoms. Subclinical abnormalities have been reported in indeterminate form of CD, including pro-inflammatory states and alterations in cardiac function, biomarkers and autonomic modulation. Moreover, individuals with CD are usually impacted on their personal and professional life, making social insertion difficult and impacting their mental health and quality of life (QoL). Physical exercise has been acknowledged as an important strategy to prevent and control numerous chronic-degenerative diseases, but unexplored in individuals with the indeterminate form of CD. The PEDI-CHAGAS study (which stands for "Home-Based Exercise Program in the Indeterminate Form of Chagas Disease" in Portuguese) aims to evaluate the effects of a home-based exercise program on physical and mental health outcomes in individuals with indeterminate form of CD., Methods and Design: The PEDI-CHAGAS is a two-arm (exercise and control) phase 3 superiority randomized clinical trial including patients with indeterminate form of CD. The exclusion criteria are <18 years old, evidence of non-Chagasic cardiomyopathy, musculoskeletal or cognitive limitations that preclude the realization of exercise protocol, clinical contraindication for regular exercise, and regular physical exercise (≥1 × per week). Participants will be assessed at baseline, and after three and 6 months of follow-up. The primary outcome will be QoL. Secondary outcomes will include blood pressure, physical fitness components, nutritional status, fatigability, autonomic modulation, cardiac morphology and function, low back pain, depression and anxiety, stress, sleep quality, medication use and adherence, and biochemical, inflammatory and cardiac biomarkers. Participants in the intervention group will undergo a home-based exercise program whilst those in the control group will receive only general information regarding the benefits of physical activity. Both groups will receive the same general nutritional counseling consisting of general orientations about healthy diets., Conclusion: The findings from the present study may support public health intervention strategies to improve physical and mental health parameters to be implemented more effectively in this population., Clinical Trial Registration: [https://ensaiosclinicos.gov.br/rg/RBR-10yxgcr9/], identifier [U1111-1263-0153]., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Mediano, Ribeiro, Silva, Xavier, Vieira, Gonçalves, Paravidino, Borges, Rodrigues Junior, Costa, Reis, Liporagi-Lopes, Martinez-Amezcua, Silva, Sperandio Da Silva, Sousa, Holanda, Veloso, Carneiro, Mazzoli-Rocha, Costa, Saraiva, Mendes, Sangenis and Hasslocher-Moreno.)
- Published
- 2023
- Full Text
- View/download PDF
13. Comparative effects of a cardiovascular rehabilitation program on functional capacity in patients with chronic chagasic cardiomyopathy with or without heart failure.
- Author
-
Viana AMN, Vieira MC, Mazzoli-Rocha F, Silva RS, Frota AX, Costa HS, Borges JP, Sperandio da Silva GM, da Silva PS, Hasslocher-Moreno AM, Saraiva RM, de Sousa AS, Mendes FSNS, and Mediano MFF
- Subjects
- Humans, Quality of Life, Retrospective Studies, Cardiac Rehabilitation, Heart Failure complications, Cardiomyopathies etiology
- Abstract
Purpose: The aim of the present study was to evaluate the effects of cardiovascular rehabilitation (CR) on functional capacity of patients with chronic chagasic cardiomyopathy (CCC) and to compare the responses between CCC patients without and with heart failure (HF)., Materials and Methods: A longitudinal observational retrospective study was carried out including 36 patients with CCC without HF (stage B2 [ n = 7]) and with HF (stage C [ n = 29]), who participated in a CR program. Functional capacity was assessed by a maximal progressive cardiopulmonary exercise test performed on a treadmill. The longitudinal effects of the CR on functional capacity were determined by linear mixed models that included an interaction term to evaluate the differential responses between patients without and with HF., Results: Significant improvements in peak oxygen consumption, resting heart rate and blood pressure, and maximum pulmonary ventilation were observed for the overall study sample, with no apparent differential effects according to the presence of HF., Conclusions: CR significantly improved functional capacity of patients with CCC. The responses to CR appear to be similar among patients without and with HF, reinforcing the need for its inclusion as a standard treatment strategy of CCC.Implications for rehabilitationExercise-based cardiovascular rehabilitation (CR) is a safe strategy that improves functional capacity, cardiac function, and quality of life in patients with several cardiovascular diseases, and recent studies also suggested a potential beneficial effect of CR in chronic chagasic cardiomyopathy (CCC).In this observational study, CR seems to equally improve exercise capacity, resting heart rate, resting blood pressure, and maximum pulmonary ventilation in patients with CCC without (stage B2) and with heart failure (stage C).Cardiovascular rehabilitation should be included as a standard treatment strategy for patients with CCC, regardless the severity of cardiomyopathy.
- Published
- 2023
- Full Text
- View/download PDF
14. The association between variables of cardiopulmonary exercise test and quality of life in patients with chronic Chagas cardiomyopathy (Insights from the PEACH STUDY).
- Author
-
Vieira MC, Mendes FSNS, Silva PSD, Silva GMSD, Mazzoli-Rocha F, Sousa AS, Saraiva RM, Quintana MSB, Costa HS, Paravidino VB, Rodrigues LF Junior, Hasslocher-Moreno AM, Americano do Brasil PEA, and Mediano MFF
- Subjects
- Humans, Quality of Life psychology, Stroke Volume, Ventricular Function, Left, Oxygen Consumption, Exercise Test methods, Chagas Cardiomyopathy
- Abstract
Studies investigating the association between functional capacity and quality of life (QoL) in individuals with chronic Chagas cardiomyopathy (CCC) usually do not include a gold-standard evaluation of functional capacity, limiting the validity and the interpretation of the results. The present study is a cross-section analysis aiming to evaluate the association between functional capacity (quantified by cardiopulmonary exercise test [CPET]) and QoL in individuals with CCC. QoL was assessed using the SF-36 questionnaire. Sociodemographic, anthropometric, clinical, cardiac function and maximal progressive CPET variables were obtained from PEACH study. Generalized linear models adjusted for age, sex, and left ventricular ejection fraction were performed to evaluate the association between CPET variables and QoL. After adjustments, VO2 peak and VO2 AT were both associated with physical functioning (β = +0.05 and β = +0.05, respectively) and physical component summary (β = +0.03 and β = +0.03, respectively). Double product was associated with physical functioning (β = +0.003), general health perceptions (β = +0.003), physical component summary (β = +0.002), and vitality (β = +0.004). HRR≤12bpm was associated with physical functioning (β = -0.32), role limitations due to physical problems (β = -0.87), bodily pain (β = -0.26), physical component summary (β = -0.21), vitality (β = -0.38), and mental health (β = -0.19). VE/VCO2 slope presented association with all mental scales of SF-36: vitality (β = -0.028), social functioning (β = -0.024), role limitations due to emotional problems (β = -0.06), mental health (β = -0.04), and mental component summary (β = -0.02). The associations between CPET variables and QoL demonstrate the importance of CPET inclusion for a more comprehensive evaluation of individuals with CCC. In this setting, intervention strategies aiming to improve functional capacity may also promote additional benefits on QoL and should be incorporated as a treatment strategy for patients with CCC., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2022 Vieira et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2022
- Full Text
- View/download PDF
15. Epidemiological-clinical profile and mortality in patients coinfected with Trypanosoma cruzi/HIV: experience from a Brazilian reference center.
- Author
-
Hasslocher-Moreno AM, Sousa AS, Xavier SS, Mendes FSNS, Nunes EP, Grinsztejn BGJ, and Mediano MFF
- Subjects
- Humans, Female, Middle Aged, Male, Brazil epidemiology, Ketoconazole therapeutic use, Trypanosoma cruzi physiology, Coinfection, HIV Infections complications, HIV Infections epidemiology, Acquired Immunodeficiency Syndrome complications, Chagas Disease complications, Chagas Disease drug therapy, Chagas Disease epidemiology
- Abstract
Background: The recent urbanization of Chagas disease (CD) has contributed to a greater risk of coexistence with human immunodeficiency virus (HIV) and AIDS., Methods: This retrospective observational study included patients who were followed at INI-Fiocruz between July 1986 and October 2021. All patients underwent an assessment protocol that included sociodemographic profile, epidemiological history, and clinical evaluation. Descriptive data analyses included reports of the medians and frequencies of variables of interest. Differences in medians between groups were tested using the Mann-Whitney U test. Differences in frequency were tested using Fisher's exact test., Results: Among 2201 patients, 11 (0.5%) were identified with Trypanosoma cruzi/HIV coinfection. Of these, 63.6% were women with a median age of 51.0 years old. Two patients had the indeterminate form of CD, six had the cardiac form, two had the digestive form and one had the cardio-digestive form. Half of the patients were undergoing antiretroviral treatment at the time of coinfection diagnosis with a median CD4+ count of 350 cells/μL and a viral load of 1500 copies/μL. Four patients underwent a xenodiagnosis test at coinfection diagnosis, which all yielded positive results; two of them presented high parasitemia under the risk of reactivation. Prophylaxis for CD reactivation was administered to four patients; two with ketoconazole and two with benznidazole. Six patients died after a median follow-up of 22.5 months, with AIDS being the most common cause of death. Only one case of reactivation was observed., Conclusions: Early diagnosis and prompt treatment of CD reactivation dramatically reduced mortality. Identification of Trypanosoma cruzi/HIV co-infection is crucial to planning a close follow-up of coinfected patients.
- Published
- 2022
- Full Text
- View/download PDF
16. The association of exercise test variables with long-term mortality in patients with chronic Chagas disease.
- Author
-
Silva RS, Mendes FSNS, Fleg JL, Rodrigues Junior LF, Vieira MC, Xavier IGG, Costa HS, Reis MS, Mazzoli-Rocha F, Costa AR, Holanda MT, Veloso HH, Sperandio da Silva GM, Sousa AS, Saraiva RM, Hasslocher-Moreno AM, and Mediano MFF
- Abstract
Background: The identification of variables obtained in the exercise test (ET) associated with increased risk of death is clinically relevant and would provide additional information for the management of Chagas disease (CD). The objective of the present study was to evaluate the association of ET variables with mortality in patients with chronic CD., Methods: This retrospective longitudinal observational study included 232 patients (median age 46.0 years; 50% women) with CD that were followed at the Evandro Chagas National Institute of Infectious Diseases (Rio de Janeiro, Brazil) and performed an ET between 1989 and 2000. The outcome of interest was all-cause mortality., Results: There were 103 deaths (44.4%) during a median follow-up of 21.5 years (IQR 25-75% 8.0-27.8), resulting in 24.5 per 1,000 patients/year incidence rate. The ET variables associated with mortality after adjustments for potential confounders were increased maximal (HR 1.02; 95% CI 1.00-1.03 per mmHg) and change (HR 1.03; 95% CI 1.01-1.06 per mmHg) of diastolic blood pressure (DBP) during ET, ventricular tachycardia at rest (HR 3.95; 95% CI 1.14-13.74), during exercise (HR 2.73; 95% CI 1.44-5.20), and recovery (HR 2.60; 95% CI 1.14-5.91), and premature ventricular complexes during recovery (HR 2.06; 1.33-3.21)., Conclusion: Our findings suggest that ET provides important prognostic value for mortality risk assessment in patients with CD, with hemodynamic (increased DBP during exercise) and electrocardiographic (presence of ventricular arrhythmias) variables independently associated with an increased mortality risk in patients with CD. The identification of individuals at higher mortality risk can facilitate the development of intervention strategies (e.g., close follow-up) that may potentially have an impact on the longevity of patients with CD., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Silva, Mendes, Fleg, Rodrigues Junior, Vieira, Xavier, Costa, Reis, Mazzoli-Rocha, Costa, Holanda, Veloso, Sperandio da Silva, Sousa, Saraiva, Hasslocher-Moreno and Mediano.)
- Published
- 2022
- Full Text
- View/download PDF
17. Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients.
- Author
-
Sperandio da Silva GM, Mediano MFF, Murgel MF, Andrade PM, de Holanda MT, da Costa AR, Veloso HH, Carneiro FM, Valete Rosalino CM, de Sousa AS, Mendes FSNS, Pinheiro RO, Veloso VG, Saraiva RM, and Hasslocher-Moreno AM
- Abstract
[This corrects the article DOI: 10.3389/fmed.2022.880796.]., (Copyright © 2022 Sperandio da Silva, Mediano, Murgel, Andrade, de Holanda, da Costa, Veloso, Carneiro, Valete Rosalino, de Sousa, Mendes, Pinheiro, Veloso, Saraiva and Hasslocher-Moreno.)
- Published
- 2022
- Full Text
- View/download PDF
18. Critical analysis of Chagas disease treatment in different countries.
- Author
-
Mendes FSNS, Perez-Molina JA, Angheben A, Meymandi SK, Sosa-Estani S, and Molina I
- Subjects
- Americas, Europe, Humans, Chagas Disease drug therapy
- Abstract
As a result of globalization and constant migratory flows, Chagas disease is now present in almost all continents. The management and treatment of the disease is often influenced by the economic and social context of the societies that host patients. In this manuscript, we aim to provide a comparative review of approaches to patients with Chagas disease in the Americas and Europe.
- Published
- 2022
- Full Text
- View/download PDF
19. Cost-effectiveness of an exercise-based cardiovascular rehabilitation program in patients with chronic Chagas cardiomyopathy in Brazil: An analysis from the PEACH study.
- Author
-
Simões VAL, Mendes FSNS, Avellar AM, da Silva GMS, Carneiro FM, Silva PS, Mazzoli-Rocha F, Silva RS, Vieira MC, Costa CJDN, de Sousa AS, Rosalino CMV, Nobre PFDS, de Holanda MT, Costa HS, Saraiva RM, Hasslocher-Moreno AM, Castro R, and Mediano MFF
- Subjects
- Brazil, Cost-Benefit Analysis, Exercise Therapy, Humans, Cardiac Rehabilitation, Chagas Cardiomyopathy
- Abstract
Objectives: The present study aimed to perform a cost-effectiveness analysis of an exercise-based cardiovascular rehabilitation (CR) program in patients with chronic Chagas cardiomyopathy (CCC)., Methods: Cost-effectiveness analysis alongside a randomised clinical trial evaluating the effects of a 6-month exercise-based CR program. The intervention group underwent 3 weekly exercise sessions. The variation of peak oxygen consumption (VO
2peak ) was used as a measurement of clinical outcome. Cost information from all healthcare expenses (examinations, healthcare visits, medication and hospitalisation) were obtained from the medical records in Brazilian reais (R$) and transformed into dollars using the purchasing power parity ($PPP). The longitudinal costs variation was evaluated through linear mixed models, represented by β coefficient, adjusted for the baseline values of the dependent variable. The cost-effectiveness evaluation was determined through an incremental cost-effectiveness ratio using the HEABS package (Stata 15.0)., Results: The intervention group presented higher costs with healthcare visits (β = +3317.3; p < 0.001), hospitalisation (β = +2810.4; p = 0.02) and total cost (β = +6407.9; p < 0.001) after 3 months of follow-up. Costs related to healthcare visits (β = +2455.8; p < 0.001) and total cost (β = +4711.4; p < 0.001) remained higher in the intervention group after 6 months. The CR program showed an incremental cost-effectiveness ratio (ICER) of $PPP 1874.3 for each increase of 1.0 ml kg-1 min-1 of VO2peak ., Conclusions: The CR program can be considered a cost-effective alternative and should be included as an intervention strategy in the care of patients with CCC., (© 2022 John Wiley & Sons Ltd.)- Published
- 2022
- Full Text
- View/download PDF
20. Prognosis of chronic Chagas heart disease and other pending clinical challenges.
- Author
-
Torres RM, Correia D, Nunes MDCP, Dutra WO, Talvani A, Sousa AS, Mendes FSNS, Scanavacca MI, Pisani C, Moreira MDCV, de Souza DDSM, de Oliveira Junior W, Martins SM, and Dias JCP
- Subjects
- Chronic Disease, Heart, Humans, Persistent Infection, Prognosis, Chagas Cardiomyopathy diagnosis, Chagas Disease, Heart Transplantation
- Abstract
In this chapter, the main prognostic markers of Chagas heart disease are addressed, with an emphasis on the most recent findings and questions, establishing the basis for a broad discussion of recommendations and new approaches to managing Chagas cardiopathy. The main biological and genetic markers and the contribution of the electrocardiogram, echocardiogram and cardiac magnetic resonance are presented. We also discuss the most recent therapeutic proposals for heart failure, thromboembolism and arrhythmias, as well as current experience in heart transplantation in patients suffering from severe Chagas cardiomyopathy. The clinical and epidemiological challenges introduced by acute Chagas disease due to oral contamination are discussed. In addition, we highlight the importance of ageing and comorbidities in influencing the outcome of chronic Chagas heart disease. Finally, we discuss the importance of public policies, the vital role of funding agencies, universities, the scientific community and health professionals, and the application of new technologies in finding solutions for better management of Chagas heart disease.
- Published
- 2022
- Full Text
- View/download PDF
21. Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients.
- Author
-
Sperandio da Silva GM, Mediano MFF, Murgel MF, Andrade PM, de Holanda MT, Rodrigues da Costa A, Horta Veoso H, de Souza ogueira Sardinha Mendes F, Valete Rosalino CM, de Sousa AS, Mendes FSNS, Valete Rosalino CM, Pinheiro RO, Veloso VG, Saraiva RM, and Hasslocher-Moreno AM
- Abstract
The COVID-19 virus infection caused by the new SARS-CoV-2 was first identified in Rio de Janeiro (RJ), Brazil, in March 2020. Until the end of 2021, 504,399 COVID-19 cases were confirmed in RJ, and the total death toll reached 68,347. The Evandro Chagas National Institute of Infectious Diseases from Oswaldo Cruz Foundation (INI-Fiocruz) is a referral center for treatment and research of several infectious diseases, including COVID-19 and Chagas disease (CD). The present study aimed to evaluate the impact of COVID-19 on in-hospital mortality of patients with CD during the COVID-19 pandemic period. This observational, retrospective, longitudinal study evaluated all patients with CD hospitalized at INI-Fiocruz from May 1, 2020, to November 30, 2021. One hundred ten hospitalizations from 81 patients with CD (58% women; 68 ± 11 years) were evaluated. Death was the study's main outcome, which occurred in 20 cases. The mixed-effects logistic regression was performed with the following variables to test whether patients admitted to the hospital with a COVID-19 diagnosis would be more likely to die than those admitted with other diagnoses: admission diagnosis, sex, age, COVID-19 vaccination status, CD clinical classification, and the number of comorbidities. Results from multiple logistic regression analysis showed a higher risk of in-hospital mortality in patients diagnosed with COVID-19 (OR 6.37; 95% CI 1.78-22.86) compared to other causes of admissions. In conclusion, COVID-19 infection had a significant impact on the mortality risk of INI-Fiocruz CD patients, accounting for one-third of deaths overall. COVID-19 presented the highest percentage of death significantly higher than those admitted due to other causes during the COVID-19 pandemic., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Sperandio da Silva, Mediano, Murgel, Andrade, de Holanda, Valete Rosalino, de Sousa, Mendes, Pinheiro, Veloso, Saraiva and Hasslocher-Moreno.)
- Published
- 2022
- Full Text
- View/download PDF
22. The CUIDA Chagas Project: towards the elimination of congenital transmission of Chagas disease in Bolivia, Brazil, Colombia, and Paraguay.
- Author
-
Sousa AS, Vermeij D, Parra-Henao G, Lesmo V, Fernández EF, Aruni JJC, Mendes FSNS, Bohorquez LC, and Luquetti AO
- Subjects
- Bolivia epidemiology, Brazil epidemiology, Colombia, Female, Humans, Paraguay epidemiology, Chagas Disease diagnosis, Chagas Disease epidemiology, Chagas Disease prevention & control, Infectious Disease Transmission, Vertical prevention & control
- Abstract
Background: Mother-to-child transmission of Chagas disease (CD) has become a relevant problem in both endemic and non-endemic areas., Methods: Description of the CUIDA Chagas Project - Communities United for Innovation, Development and Attention for Chagas disease'., Results: Through innovative and strategic research, this project will provide improved diagnostic and treatment options as well as replicable implementation models that are adaptable to different contexts., Conclusions: By integrating test, treat and care actions for CD into primary health care practices, the burden of CD on people and health systems may be significantly reduced.
- Published
- 2022
- Full Text
- View/download PDF
23. Acute and subacute hemodynamic responses and perception of effort in subjects with chronic Chagas cardiomyopathy submitted to different protocols of inspiratory muscle training: a cross-over trial.
- Author
-
Frota AX, Mendes FSNS, Vieira MC, Saraiva RM, Veloso HH, da Silva PS, Sperandio da Silva GM, de Sousa AS, Mazzoli-Rocha F, Costa HS, Rodrigues Junior LF, and Mediano MFF
- Subjects
- Breathing Exercises methods, Cross-Over Studies, Humans, Perception, Randomized Controlled Trials as Topic, Stroke Volume, Ventricular Function, Left, Chagas Cardiomyopathy therapy, Respiratory Muscles
- Abstract
Purpose: This study aimed to evaluate acute and subacute hemodynamic responses and perception of effort in individuals with CCC submitted to different IMT protocols., Materials and Methods: This was a randomized cross-over trial conducted on CCC subjects with systolic left ventricular dysfunction (<45% left ventricular ejection fraction) without or with heart failure (stages B2 and C, respectively). Twenty-one participants performed two IMT protocols, one targeting 60% maximal inspiratory pressure with 3 × 10 repetitions (MIP60) and the other targeting 30% maximal inspiratory pressure (MIP30) with 3 × 20 repetitions with a 2 min recovery between sets for both. MIP60 and MIP30 were performed on the same day with a 2 h washout period. Measurements were taken at baseline, during and 60 min after IMT., Results: No differences in hemodynamic variables were observed across protocols. The perception of effort increased in both protocols, with higher scores for the MIP30 protocol (β = +1.6, p = 0.01; β = +1.1, p = 0.02; β = +0.9, p = 0.08 for the 1st, 2nd and 3rd sets, respectively)., Conclusions: There were no differences in hemodynamic responses comparing MIP60 and MIP30 protocols in subjects with CCC. Despite the higher perception of effort during endurance protocol, both protocols can be considered a safe therapeutic strategy.IMPLICATIONS FOR REHABILITATIONDespite inspiratory muscle training may result in functional capacity improvements, no previous study evaluated the hemodynamic acute and subacute responses to inspiratory muscle training in chronic Chagas cardiomyopathy.The two inspiratory muscle training protocols (30% and 60% of maximal inspiratory pressure) did not cause significant hemodynamic repercussions in subjects with chronic Chagas cardiomyopathy.Inspiratory muscle training seems to be an effective strategy to improve functional capacity and can be implemented in the rehabilitation programs for patients with Chagas cardiomyopathy.Since no significant adverse responses were observed in any of the hemodynamic parameters during the inspiratory muscle training sessions, these two protocols of inspiratory muscle training (30% and 60% of maximal inspiratory pressure) seems to be safe in subjects with Chagas cardiomyopathy.
- Published
- 2022
- Full Text
- View/download PDF
24. Chagas disease mortality during the coronavirus disease 2019 pandemic: A Brazilian referral center experience.
- Author
-
Hasslocher-Moreno AM, Saraiva RM, Silva GMSD, Xavier SS, Sousa AS, Costa ARD, Mendes FSNS, and Mediano MFF
- Subjects
- Humans, Pandemics, Referral and Consultation, Retrospective Studies, SARS-CoV-2, COVID-19, Chagas Disease epidemiology
- Abstract
Background: We investigated the mortality rates of patients with Chagas disease (CD) during the coronavirus disease 2019 (COVID-19) pandemic and assessed the association between this mortality and CD clinical presentation and comorbidities., Methods: This was an observational retrospective study with clinical data retrieved from medical records., Results: Comorbidities were more prevalent among patients who died from COVID-19 than those who died from other causes. The proportion of patients according to CD clinical presentation was similar between the two groups., Conclusions: The prevalence of comorbidities seems to be related to a poorer prognosis in CD and COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
25. Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease.
- Author
-
Saraiva RM, Mediano MFF, Quintana MSB, Sperandio da Silva GM, Costa AR, Sousa AS, Sangenis LHC, Mendes FSNS, Veloso HH, Xavier SS, Holanda MT, and Hasslocher-Moreno AM
- Abstract
Background: Patients with chronic Chagas disease (CD) cardiomyopathy have a high mortality. We evaluated if two-dimensional (2D) strain ( ε ) parameters provide independent predictors of progression to CD cardiomyopathy and all-cause mortality., Methods: A total of 408 patients with chronic CD (58.6% women; 53 ± 11 years; clinical forms: indeterminate 34.1%, cardiac 57.6%, digestive 1.2%, cardiodigestive 7.1%) were consecutively included in this single-center prospective longitudinal study. Echocardiographic evaluation included left atrial and left ventricular (LV) function on ε analyses. Primary end-point was a composite of all-cause mortality or heart transplant. Secondary end-point was CD progression defined as the occurrence of changes typical of CD in electrocardiogram, sustained ventricular tachycardia, wall motion abnormalities, or heart failure among patients with the indeterminate form at baseline. Multivariable Cox-proportional-hazards regression analyses were performed to test if 2D ε parameters were associated with the studied end-points. P values < 0.05 were considered significant., Results: The primary end-point occurred in 91 patients after a follow-up of 6.5 ± 2.7 years. CD progression occurred in 26 out of 144 patients without cardiac form at baseline (2.88 cases/100 patient-years). Peak LV circumferential (HR 1.09, 95% CI 1.01-1.18, P = .02) and radial (HR 0.97, 95% CI 0.95-0.99, P = .007) ε , and LV torsion (HR 0.51, 95% CI 0.35-0.74, P = .0004) were independent predictors of the primary end-point. Peak LV radial ε (HR 0.96, 95% CI 0.93-0.99, P = .03) was an independent predictor of CD progression., Conclusions: Therefore, 2D ε derived parameters can be useful for CD progression and mortality prediction., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
26. Temporal changes in the clinical-epidemiological profile of patients with Chagas disease at a referral center in Brazil.
- Author
-
Hasslocher-Moreno AM, Saraiva RM, Brasil PEAAD, Sangenis LHC, Xavier SS, Sousa AS, Sperandio-da-Silva GM, Mendes FSNS, Costa ARD, Holanda MT, Veloso HH, Mazzoli-Rocha F, Carneiro FM, Portela LF, and Mediano MFF
- Subjects
- Aged, Brazil epidemiology, Female, Humans, Male, Middle Aged, Prevalence, Referral and Consultation, Retrospective Studies, Chagas Disease diagnosis, Chagas Disease epidemiology
- Abstract
Introduction: We aimed to describe the sociodemographic, epidemiological, and clinical characteristics of patients with chronic Chagas disease (CD) at an infectious disease referral center. Changes in patient profiles over time were also evaluated., Methods: This retrospective study included patients with CD from November 1986-December 2019. All patients underwent an evaluation protocol that included sociodemographic profile; epidemiological history; anamnesis; and physical, cardiologic, and digestive examinations. Trend differences for each 5-year period from 1986 to 2019 were tested using a nonparametric trend test for continuous and generalized linear models with binomial distribution for categorical variables., Results: A total of 2,168 patients (52.2% women) were included, with a mean age of 47.8 years old. White patients with low levels of education predominated. The reported transmission mode was vectorial in 90.2% of cases. The majority came from areas with a high prevalence (52.2%) and morbidity (67.8%) of CD. The most common clinical presentation was the indeterminate form (44.9%). The number of patients referred gradually decreased and the age at admission increased during the study period, as did the patients' levels of education., Conclusions: The clinical profile of CD is characterized by a predominance of the indeterminate form of the disease. Regarding the patients who were followed up at the referral center, there was a progressive increase in the mean age and a concomitant decrease in the number of new patients. This reflects the successful control of vector and transfusion transmission in Brazil as well as the aging population of patients with CD.
- Published
- 2021
- Full Text
- View/download PDF
27. Prevalence of metabolic syndrome and associated factors among patients with chronic Chagas disease.
- Author
-
Xavier IGG, Vieira MC, Rodrigues Junior LF, Sperandio da Silva GM, da Silva PS, de Holanda MT, Maciel ER, Carneiro FM, Mazzoli-Rocha F, Sangenis LHC, Mendes FSNS, Hasslocher-Moreno AM, de Sousa AS, da Costa AR, Saraiva RM, do Brasil PEAA, and Mediano MFF
- Subjects
- Adult, Brazil, Chagas Disease epidemiology, Female, Humans, Male, Middle Aged, Prevalence, Chagas Disease complications, Metabolic Syndrome epidemiology
- Abstract
The increase in life expectancy and the migration of individuals with Chagas disease (ChD) from rural to urban centers exposes them to the development of chronic-degenerative abnormalities that may increase the prevalence of metabolic syndrome (MetS). The present study aimed to identify the prevalence of MetS and its components in individuals with chronic ChD. This is a cross-sectional study with 361 patients of both sexes, aging >18 years, followed at a national reference center (Rio de Janeiro, Brazil). MetS diagnosis followed the International Diabetes Federation 2005 criteria. The association between the variables was determined through logistic regression models. The mean age was and 60.7±10.8 years. About half (56.2%) were female and the majority self-reported their race as mulatto (59.8%). The percentage of individuals with MetS was 40.4%. The variables independently associated with MetS were age (OR 1.06; 95%CI 1.04-1.09), high education levels (OR 0.36; 95%CI 0.17-0.79) and cardiac form with heart failure (OR 0.34; 95%CI 0.17-0.68). Therefore, a high prevalence of MetS was found in this Brazilian chronic ChD cohort. The identification of the associated factors can facilitate the development of effective approaches for preventing and managing MetS in ChD patients., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
28. Exercise training improves microvascular function in patients with Chagas heart disease: Data from the PEACH study.
- Author
-
Borges JP, Mendes FSNS, Rangel MVDS, Lopes GO, da Silva GMS, da Silva PS, Mazzoli-Rocha F, Saraiva RM, de Sousa AS, Tibirica E, and Mediano MFF
- Subjects
- Aged, Brazil, Chagas Cardiomyopathy diagnostic imaging, Chagas Cardiomyopathy parasitology, Chagas Cardiomyopathy physiopathology, Female, Humans, Male, Middle Aged, Recovery of Function, Regional Blood Flow, Time Factors, Treatment Outcome, Cardiac Rehabilitation, Chagas Cardiomyopathy rehabilitation, Exercise Therapy, Microcirculation, Skin blood supply
- Abstract
Background: Chagas heart disease (CHD) impairs the systemic microvascular function. We investigated the effects of exercise training on cutaneous microvascular function among patients with CHD., Methods: Patients from the PEACH study were randomly assigned to a supervised exercise training 3 times/week for 6 months (Trained; n = 10) or a control group (Untrained; n = 8). Both groups underwent evaluation of microvascular function before, and at 3- and 6-months of follow-up. Cutaneous vascular conductance (CVC) was assessed in the skin of the forearm using laser speckle contrast imaging coupled with iontophoresis of acetylcholine (ACh), sodium nitroprusside (SNP) and during post-occlusive reactive hyperemia (PORH)., Results: At 3-months of follow-up, no difference was detected between groups in CVC responses to ACh (p = 0.50), SNP (p = 0.26) and HRPO (p = 0.65). However, at 6-months of follow-up, trained vs. untrained patients improved CVC induced by SNP-iontophoresis (0.19 ± 0.10 vs. 0.14 ± 0.15 APU.mmHg
-1 ; p = 0.05) and PORH (0.63 ± 0.15 vs. 0.48 ± 0.18 APU.mmHg-1 ; p = 0.05). CVC response to ACh-iontophoresis was similar between groups (0.19 ± 0.11 vs. 0.22 ± 0.17 APU.mmHg-1 ; p = 0.38)., Conclusion: Exercise training performed during 6 months improved the cutaneous microvascular function of CHD patients. Further studies evaluating the mechanism involved in this response are warranted., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
29. Factors related to the discontinuation and mortality rates of a cardiac rehabilitation programme in patients with Chagas disease: a 6-year experience in a Brazilian tertiary centre.
- Author
-
Vieira MC, Mendes FSNS, Mazzoli-Rocha F, Silva RS, Viana AMN, Frota AX, da Silva GMS, da Silva PS, Hasslocher-Moreno AM, Saraiva RM, de Sousa AS, and Mediano MFF
- Subjects
- Aged, Brazil epidemiology, Chagas Disease classification, Female, Humans, Longitudinal Studies, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, Socioeconomic Factors, Survival Analysis, Tertiary Care Centers, Cardiac Rehabilitation mortality, Chagas Disease mortality, Patient Dropouts statistics & numerical data
- Abstract
Objectives: To describe the clinical and sociodemographic characteristics of participants as well as discontinuation and mortality rates in a cardiac rehabilitation programme (CRP) tailored to Chagas disease (CD)., Methods: Participants underwent functional capacity, anthropometry and cardiac function evaluations before beginning a CRP. Univariate and multivariate Cox proportional hazards models were performed to investigate the associations between clinical and sociodemographic characteristics at baseline with discontinuation rates and deaths., Results: Forty-two patients were enrolled in the CRP (61.9% men, mean age of 58.1 ± 11.8 years). During a median follow-up period of 10.8 months, 74% discontinued and 14% died while enrolled in CRP. 34% of the patients who discontinued CRP died during follow-up. White race (HR = 0.09; 95% CI 0.01-1.00), right ventricular systolic dysfunction (HR = 10.54; 95% CI 1.24-89.50) and oxygen pulse (HR = 0.69; 95% CI 0.48-0.99) were independently associated with death while enrolled in CRP. Married status (HR = 0.44; 95% CI 0.21-0.95) was independently associated with discontinuation rates from CRP. VO
2 peak (HR = 0.85; 95% CI 0.74-0.98) and CRP discontinuation due to CD-related reasons (HR = 8.33; 95% CI 1.91-36.27) were the variables independently associated with death after discontinuation of CRP., Conclusion: In this population, sociodemographic aspects and severity of CD were important determinants of CRP discontinuation and mortality., (© 2021 John Wiley & Sons Ltd.)- Published
- 2021
- Full Text
- View/download PDF
30. Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges.
- Author
-
Frota AX, Vieira MC, Soares CCS, Silva PSD, Silva GMSD, Mendes FSNS, Mazzoli-Rocha F, Veloso HH, Costa ADD, Lamas CDC, Valete-Rosalino CM, Gonçalves TR, Costa HS, Rodrigues Junior LF, and Mediano MFF
- Subjects
- Hospitalization, Humans, SARS-CoV-2, COVID-19, Heart Failure, Myocarditis
- Abstract
Covid-19 is a novel infectious disease whose spectrum of presentation ranges from absence of symptoms to widespread interstitial pneumonia associated with severe acute respiratory syndrome (SARS), leading to significant mortality. Given the systemic pattern of Covid-19, there are many factors that can influence patient's functional capacity after acute infection and the identification of such factors can contribute to the development of specific rehabilitation strategies. Pulmonary impairment is the primary cause of hospitalization due to Covid-19, and can progress to SARS as well as increase length of hospitalization. Moreover, cardiac involvement is observed in approximately 30% of hospitalized patients, with an increased risk of acute myocarditis, myocardial injury, and heart failure, which may compromise functional capacity in the long-term. Thromboembolic complications have also been reported in some patients with Covid-19 and are associated with a poor prognosis. Musculoskeletal complications may result from long periods of hospitalization and immobility, and can include fatigue, muscle weakness and polyneuropathy. Studies that address the functional capacity of patients after Covid-19 infection are still scarce. However, based on knowledge from the multiple systemic complications associated with Covid-19, it is reasonable to suggest that most patients, especially those who underwent prolonged hospitalization, will need a multiprofessional rehabilitation program. Further studies are needed to evaluate the functional impact and the rehabilitation strategies for patients affected by Covid-19.
- Published
- 2021
- Full Text
- View/download PDF
31. Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study.
- Author
-
Hasslocher-Moreno AM, Saraiva RM, Sangenis LHC, Xavier SS, de Sousa AS, Costa AR, de Holanda MT, Veloso HH, Mendes FSNS, Costa FAC, Boia MN, Brasil PEAA, Carneiro FM, da Silva GMS, and Mediano MFF
- Abstract
Background: Chagas disease (CD) remains an important endemic disease in Latin America. However, CD became globalized in recent decades. The majority of the chronically infected individuals did not receive etiologic treatment for several reasons, among them the most conspicuous is the lack of access to diagnosis. The impact of trypanocidal treatment on CD chronic phase, without cardiac involvement (indeterminate form ICF), is yet to be determined. We aimed to evaluate the effect of trypanocidal treatment with benznidazole (BZN) on the rate of progression to Chagas heart disease in patients with ICF., Methods: This is a retrospective cohort observational study including patients with ICF treated with BZN and compared to a group of non-treated patients matched for age, sex, region of origin, and the year of cohort entry. We reviewed the medical charts of all patients followed from May 1987 to June 2020 at the outpatient center of the Evandro Chagas National Institute of Infectious Diseases (INI) of the Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil. Patients' follow-up included at least one annual medical visit and one annual electrocardiogram (ECG). Echocardiographic exams were performed at baseline and during the follow-up. Disease progression from ICF to cardiac form was defined by changes in baseline ECG. Cumulative incidence and the incidence rate were described in the incidence analysis. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals for the association between BZN and CD progression, cardiovascular events or death., Findings: One hundred and fourteen treated patients met the study inclusion criteria. A comparison group of 114 non-treated patients matched for age, sex, region of origin, and the year of cohort entry was also included, totalizing 228 patients. Most patients included in the study were male (70.2%), and their mean age was 31.3 (+7.4) years. Over a median follow-up of 15.1 years (ranging from 1.0 to 32.4), the cumulative CD progression incidence in treated patients was 7.9% vs. 21.1% in the non-treated group ( p = 0.04) and the CD progression rate was 0.49 per 1.000 patients/year in treated patients vs. 1.10 per 1.000 patients/year for non-treated patients ( p = 0.02). BZN treatment was associated with a decreased risk of CD progression in both unadjusted (HR 0.46; 95%CI 0.21 to 0.98) and adjusted (HR 0.43; 95%CI 0.19 to 0.96) models and with a decreased risk of occurrence of the composite of cardiovascular events only in the adjusted (HR 0.15; 95%CI 0.03 to 0.80) model. No association was observed between BZN treatment and mortality., Interpretation: In a long-term follow-up, BZN treatment was associated with a decreased incidence of CD progression from ICF to the cardiac form and also with a decreased risk of cardiovascular events. Therefore, our results indicate that BZN treatment for CD patients with ICF should be implemented into clinical practice., Competing Interests: The authors declare no conflict of interest., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
32. Left Atrial Structure and Function Predictors of New-Onset Atrial Fibrillation in Patients with Chagas Disease.
- Author
-
Saraiva RM, Pacheco NP, Pereira TOJS, Costa AR, Holanda MT, Sangenis LHC, Mendes FSNS, Sousa AS, Hasslocher-Moreno AM, Xavier SS, Mediano MFF, and Veloso HH
- Subjects
- Adult, Female, Heart Atria diagnostic imaging, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Atrial Fibrillation diagnostic imaging, Chagas Disease complications, Chagas Disease diagnosis
- Abstract
Background: Atrial fibrillation (AF) carries ominous consequences in patients with Chagas disease. The aim of this study was to determine whether left atrial (LA) volume and function assessed using three-dimensional echocardiographic (3DE) imaging and two-dimensional speckle-tracking echocardiographic deformation analysis of strain (ε) could predict new-onset AF in patients with Chagas disease., Methods: A total of 392 adult patients with chronic Chagas disease (59% women; mean age, 53 ± 11 years) who underwent echocardiography were consecutively enrolled in this prospective longitudinal study. Echocardiographic evaluation included two-dimensional (2D) Doppler echocardiography, with evaluation of left ventricular systolic and diastolic function, LA size, and LA and left ventricular function on 3DE and ε analyses. Multivariate Cox proportional-hazards regression analysis models adjusting for age, sex, hypertension, presence of a pacemaker, and 2D Doppler echocardiographic parameters were used to test if the variables of interest had independent prognostic value for AF prediction., Results: Patients with Chagas disease were followed for 5.6 ± 2.7 years. Among these, 139 (35.5%) had the indeterminate form, 224 (57.1%) had the cardiac form, five (1.3%) had the digestive form, and 24 (6.1%) had the cardiodigestive form. The study end point of AF occurred in 45 patients. Total LA emptying fraction (hazard ratio, 0.93; 95% CI, 0.89-0.98; P = .002), passive LA emptying fraction (HR, 0.95; 95% CI, 0.91-0.99; P = .02), and peak negative global LA ε (HR, 1.22; 95% CI, 1.05-1.41; P = .01) were predictors of new-onset AF independent of clinical and 2D Doppler echocardiographic parameters., Conclusions: LA function assessed on 3DE and ε analyses predicts new-onset AF in patients with Chagas disease independent of clinical and 2D Doppler echocardiographic indexes., (Copyright © 2020 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
33. Comprehensive care for patients with Chagas cardiomyopathy during the coronavirus disease pandemic.
- Author
-
Mazzoli-Rocha F, Mendes FSNS, Silva PS, Silva GMSD, Mediano MFF, and Sousa AS
- Subjects
- COVID-19, Humans, Pandemics, Trypanosoma cruzi, Chagas Cardiomyopathy therapy, Coronavirus Infections epidemiology, Pneumonia, Viral epidemiology
- Published
- 2020
- Full Text
- View/download PDF
34. Associations between Cardiac Magnetic Resonance T1 Mapping Parameters and Ventricular Arrhythmia in Patients with Chagas Disease.
- Author
-
Pinheiro MVT, Moll-Bernardes RJ, Camargo GC, Siqueira FP, Azevedo CF, Holanda MT, Mendes FSNS, Sangenis LHC, Mediano MFF, and Sousa AS
- Subjects
- Aged, Area Under Curve, Case-Control Studies, Chagas Cardiomyopathy complications, Chagas Cardiomyopathy diagnostic imaging, Chagas Disease complications, Chagas Disease diagnostic imaging, Chagas Disease physiopathology, Cross-Sectional Studies, Echocardiography, Electrocardiography, Ambulatory, Extracellular Space, Female, Fibrosis, Humans, Logistic Models, Magnetic Resonance Imaging, Magnetic Resonance Imaging, Cine, Male, Middle Aged, Myocardium pathology, Organ Size, ROC Curve, Stroke Volume, Tachycardia, Ventricular etiology, Ventricular Function, Right, Chagas Cardiomyopathy physiopathology, Heart diagnostic imaging, Tachycardia, Ventricular physiopathology
- Abstract
Chronic Chagas disease can progress to myocardial involvement with intense fibrosis, which may predispose patients to sudden cardiac death through ventricular arrhythmia. The associations of myocardial fibrosis detected by cardiac magnetic resonance (CMR) parameters with non-sustained ventricular tachycardia (NSVT) were evaluated. This cross-sectional study included patients in early stages of Chagas disease ( n = 47) and a control group ( n = 15). Patients underwent cardiac evaluation, including CMR examination. Myocardial fibrosis assessment by CMR with measurement of late gadolinium enhancement (LGE), native T1, and extracellular volume (ECV) was performed. There was an increase in myocardial fibrosis CMR parameters and ventricular arrhythmias among different stages of Chagas disease, combined with a decrease in the left ventricular ejection fraction (LVEF) by CMR and also in the right ventricular systolic function by S' wave on tissue Doppler. Fibrosis mass and ECV were associated with the Rassi score, ventricular extrasystole, and E/e' ratio in a logistic regression model adjusted for age and gender. The ECV maintained an association with the presence of NSVT, even after adjustments for fibrosis mass and LVEF assessed by CMR. The receiver-operating characteristic area under the curve for global ECV (0.85; 95% CI: 0.71-0.99) and NSVT was greater than that for fibrosis mass (0.75; 95% CI: 0.54-0.96), although this difference was not statistically significant. Extracellular volume could be an early marker of increased risk of ventricular arrhythmia in Chagas disease, presenting an independent association with NSVT in the initial stages of chronic Chagas cardiomyopathy, even after adjustment for fibrosis mass and LVEF.
- Published
- 2020
- Full Text
- View/download PDF
35. Discussing the Score of Cardioembolic Ischemic Stroke in Chagas Disease.
- Author
-
Mendes FSNS, Mediano MFF, Silva RS, Xavier SS, do Brasil PEAA, Saraiva RM, Hasslocher-Moreno AM, and de Sousa AS
- Abstract
Chagas disease is an important infection in Latin America but it is also reported in non-endemic countries all over the world. Around 30% of infected patients develop chronic Chagas cardiopathy, which is responsible for most poor outcomes, mainly heart failure, arrhythmias and thromboembolic events. Of all thromboembolic events, stroke is the most feared, due to the high probability of evolution to death or disability. Despite its importance, the actual incidence of cardioembolic ischemic stroke in Chagas disease is not completely known. The Instituto de Pesquisa Evandro Chagas/Fundação Oswaldo Cruz (IPEC-FIOCRUZ) score aims to propose prophylaxis strategies against cardioembolic ischemic stroke in Chagas disease based on clinical risk-benefit. To date, the IPEC-FIOCRUZ score is considered the best tool to identify patients for stroke prophylaxis in Chagas disease according the Latin American guideline and Brazilian consensus. It can prevent many cardioembolic strokes that would not be predicted, by applying the current recommendations to other cardiopathies. However, the IPEC-FIOCRUZ score still requires external validation to be used in different Chagas disease populations with an appropriate study design., Competing Interests: The authors declare no conflict of interest.
- Published
- 2020
- Full Text
- View/download PDF
36. Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort.
- Author
-
Hasslocher-Moreno AM, Xavier SS, Saraiva RM, Sangenis LHC, Holanda MT, Veloso HH, Costa ARD, Mendes FSNS, Brasil PEAAD, Silva GMSD, Mediano MFF, and Sousa AS
- Abstract
Most patients with chronic Chagas disease (CD) present the indeterminate form and are at risk to develop the cardiac form. However, the actual rate of progression to the cardiac form is still unknown., Methods: In total, 550 patients with the indeterminate CD form were followed by means of annual electrocardiogram at our outpatient clinic. The studied endpoint was progression to cardiac form defined by the appearance of electrocardiographic changes typical of CD. The progression rate was calculated as the cumulative progression rate and the incidence progression rate per 100 patient years., Results: Thirty-seven patients progressed to the CD cardiac form within a mean of 73 ± 4 8 months of follow-up, which resulted in a 6.9% cumulative progression rate and incidence rate of 1.48 cases/100 patient years. Patients who progressed were older (mean age 47.8 ± 12.2 years), had a higher prevalence of associated heart diseases (p < 0.0001), positive xenodiagnosis (p = 0.007), and were born in the most endemic Brazilian states (p = 0.018). Previous co-morbidities remained the only variable associated with CD progression after multivariate Cox proportional hazards regression analysis (p = 0.002)., Conclusion: The progression rate to chronic CD cardiac form is low and inferior to rates previously reported in other studies., Competing Interests: The authors declare no conflict of interest.
- Published
- 2020
- Full Text
- View/download PDF
37. New Imaging Parameters to Predict Sudden Cardiac Death in Chagas Disease.
- Author
-
Moll-Bernardes RJ, Rosado-de-Castro PH, Camargo GC, Mendes FSNS, Brito ASX, and Sousa AS
- Abstract
Chronic Chagas' cardiomyopathy is the most severe and frequent manifestation of Chagas disease, and has a high social and economic burden. New imaging modalities, such as strain echocardiography, nuclear medicine, computed tomography and cardiac magnetic resonance imaging, may detect the presence of myocardial fibrosis, inflammation or sympathetic denervation, three conditions associated with risk of sudden death, providing additional diagnostic and/or prognostic information. Unfortunately, despite its high mortality, there is no clear recommendation for early cardioverter-defibrillator implantation in patients with Chagas heart disease in the current guidelines. Ideally, the risk of sudden cardiac death may be evaluated in earlier stages of the disease using new image methods to allow the implementation of primary preventive strategies.
- Published
- 2020
- Full Text
- View/download PDF
38. Case Report: Malignant Ventricular Arrhythmias Mimicking Acute Coronary Syndrome in Chagas Disease.
- Author
-
Moll-Bernardes RJ, Saraiva RM, Oliveira RS, Pinheiro MVT, Camargo GC, Brito ASX, Almeida SA, Siqueira FPR, Mendes FSNS, Barbosa RM, Xavier SS, Rosado de Castro PH, and Sousa AS
- Subjects
- Aged, Amiodarone administration & dosage, Amiodarone therapeutic use, Anti-Arrhythmia Agents administration & dosage, Anti-Arrhythmia Agents therapeutic use, Clopidogrel administration & dosage, Clopidogrel therapeutic use, Defibrillators, Implantable, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors administration & dosage, Platelet Aggregation Inhibitors therapeutic use, Arrhythmias, Cardiac etiology, Chagas Cardiomyopathy complications
- Abstract
Chronic Chagas heart disease has different clinical manifestations including arrhythmias, heart failure, and stroke. Chest pain is one of the most common symptoms and when associated with changes in the electrocardiogram, such as T-wave changes, electrically inactive areas, and segmental wall motion abnormalities, may lead to a misdiagnosis of acute coronary syndrome (ACS). Here, we describe two patients with Chagas heart disease and syncope due to sustained ventricular tachycardia who were misdiagnosed with ACS, and discuss the role of novel imaging modalities in the differential diagnosis and risk stratification.
- Published
- 2020
- Full Text
- View/download PDF
39. A cardiac rehabilitation exercise program potentially inhibits progressive inflammation in patients with severe Chagas cardiomyopathy: A pilot single-arm clinical trial.
- Author
-
Rodrigues Junior LF, Mendes FSNS, Pinto VLM, da Silva PS, Sperandio da Silva GM, Pinheiro RO, de Sousa AS, and Mediano MFF
- Abstract
Background: Cardiac rehabilitation exerts anti-inflammatory effect on several cardiovascular diseases; however, these effects were not described for Chagas cardiomyopathy, which is associated with pro-inflammatory imbalance., Materials and Methods: Ten patients with severe Chagas cardiomyopathy performed 8 months of exercise training in a cardiac rehabilitation program. Interleukin-1 beta (IL-1β), IL-8, IL-10, interferon gamma (IF-γ), tumor necrosis factor alpha (TNF-α), and monocyte chemoattractant protein-1 (MCP-1) serum levels were measured using enzyme-linked immunosorbent assay at baseline, 4, and 8 months. The influence of exercise on cytokine levels was evaluated using the one-way analysis of variance for repeated measurements, with Bonferroni posttest for multiple comparisons., Results: Levels of pro-inflammatory (TNF-α, IL-1β, IL-8, IF-γ, and (MCP-1) and anti-inflammatory (IL-10) cytokines did not vary significantly during the observation period., Conclusion: Exercise may benefit patients with severe Chagas cardiomyopathy by curbing the production of pro-inflammatory cytokines in this disease characterized by a continuous state of inflammation., Competing Interests: There are no conflicts of interest., (Copyright: © 2020 Journal of Research in Medical Sciences.)
- Published
- 2020
- Full Text
- View/download PDF
40. Quality of life and associated factors in patients with chronic Chagas disease.
- Author
-
Santos-Filho JCL, Vieira MC, Xavier IGG, Maciel ER, Rodrigues Junior LF, Curvo EOV, Pereira IM, Quintana MSB, Sperandio da Silva GM, Veloso HH, Mendes FSNS, Hasslocher-Moreno AM, Sousa AS, do Brasil PEAA, Saraiva RM, and Mediano MFF
- Subjects
- Adult, Aged, Aged, 80 and over, Brazil, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Socioeconomic Factors, Surveys and Questionnaires, Attitude to Health, Chagas Disease psychology, Chronic Disease psychology, Patients psychology, Quality of Life psychology
- Abstract
Objectives: To evaluate the quality of life (QoL) of patients with Chagas disease (CD) and the association between QoL domains and several clinical, socioeconomic and lifestyle characteristics of this population., Methods: Cross-sectional observational study conducted from March 2014 to March 2017 including a total of 361 outpatients followed at Evandro Chagas National Institute of Infectious Disease, Brazil. QoL was assessed using the Portuguese shorter version of the original WHO Quality of Life questionnaire (WHOQOL-BREF). Information about clinical CD presentation, presence of comorbidities, functional class, previous benznidazole treatment, socioeconomic profile and lifestyle was also obtained., Results: Environment and physical domains presented the worst QoL scores, while the social relationship domain presented the highest score. Multivariate regression analysis demonstrated that variables independently associated with QoL were functional class, sex, clinical presentation of CD, sleep duration, schooling, physical activity level, smoking, income per capita and residents by domicile., Conclusions: The low socioeconomic status and the physical limitations imposed by the disease presented an important impact on the QoL reduction among CD patients, especially on environment and physical domains. Strategies to improve QoL among CD patients should be tailored and consider many different variables to maximise improvements not only of patients' physical but also of their mental health., (© 2018 John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
41. Is endothelial microvascular function equally impaired among patients with chronic Chagas and ischemic cardiomyopathy?
- Author
-
Borges JP, Mendes FSNS, Lopes GO, Sousa AS, Mediano MFF, and Tibiriçá E
- Subjects
- Aged, Cardiomyopathies diagnosis, Cardiomyopathies epidemiology, Chagas Disease diagnosis, Chagas Disease epidemiology, Cross-Sectional Studies, Female, Humans, Male, Microcirculation physiology, Middle Aged, Myocardial Ischemia diagnosis, Stroke Volume physiology, Cardiomyopathies physiopathology, Chagas Disease physiopathology, Endothelium, Vascular physiology, Microvessels physiopathology, Myocardial Ischemia physiopathology
- Abstract
Background: Chronic Chagas cardiomyopathy (CCC) and cardiomyopathies due to other etiologies involve differences in pathophysiological pathways that are still unclear. Systemic microvascular abnormalities are associated with the pathogenesis of ischemic heart disease. However, systemic microvascular endothelial function in CCC remains to be elucidated. Thus, we compared the microvascular endothelial function of patients presenting with CCC to those with ischemic cardiomyopathy disease., Methods: Microvascular reactivity was assessed in 21 patients with cardiomyopathy secondary to Chagas disease, 21 patients with cardiomyopathy secondary to ischemic disease and 21 healthy controls. Microvascular blood flow was assessed in the skin of the forearm using laser speckle contrast imaging coupled with iontophoresis of acetylcholine (ACh)., Results: Peak increase in forearm blood flow with ACh iontophoresis in relation to baseline was greater in healthy controls than in patients with heart disease (controls: 162.7 ± 58.4% vs. ischemic heart disease: 74.1 ± 48.3% and Chagas: 85.1 ± 68.1%; p < 0.0001). Patients with Chagas and ischemic cardiomyopathy presented similar ACh-induced changes from baseline in skin blood flow (p = 0.55)., Conclusion: Endothelial microvascular function was equally impaired among patients with CCC and ischemic cardiomyopathy., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
42. Reassessment of quality of life domains in patients with compensated Chagas heart failure after participating in a cardiac rehabilitation program.
- Author
-
Mediano MFF, Mendes FSNS, Pinto VLM, Silva PSD, Hasslocher-Moreno AM, and Sousa AS
- Subjects
- Cardiac Rehabilitation psychology, Chagas Cardiomyopathy psychology, Female, Heart Failure parasitology, Heart Failure psychology, Humans, Male, Middle Aged, Treatment Outcome, Cardiac Rehabilitation methods, Chagas Cardiomyopathy rehabilitation, Heart Failure rehabilitation, Quality of Life psychology
- Abstract
Introduction:: We evaluated the effects of a cardiac rehabilitation program on quality of life., Methods: This secondary analysis of a single-arm study included 12 patients with Chagas heart failure. The cardiac rehabilitation program comprised exercise training and nutritional and pharmaceutical counseling. Quality of life was assessed using the SF-36 questionnaire., Results:: The program promoted improved physical functioning (β= +5.7; p=0.003), role-physical (β= +1.9; p=0.03), and bodily pain (β= +3.5; p=0.02) scores. Moreover, the summary physical health score (β= +1.4; p=0.001) improved., Conclusion:: The cardiac rehabilitation program significantly improved the physical quality of life of patients with Chagas heart failure.
- Published
- 2017
- Full Text
- View/download PDF
43. Prediction Models for Decision-Making on Chagas Disease.
- Author
-
Mendes FSNS and Brasil PEAAD
- Subjects
- Chagas Disease diagnosis, Humans, Risk Assessment, Chagas Disease therapy, Decision Making, Models, Theoretical
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.